PHARBE 503
Pharmaceutics II
Covers phases II and III of the drug development process. Topics include clinical study design, safety, pharmacology, and statistics. Provides an overview of the preparation and filing of the New Drug Application (NDA). Uses case studies to demonstrate key concepts. Prerequisite: PHARBE 502 or permission of instructor. Offered: S.
Topics
- clinical study design
- safety
- pharmacology
- and statistics
Topics explicitly listed in official catalogue description
Sources
- Course catalogue ↗Current public catalogue; retrieved 2026-11-05